vs
Side-by-side financial comparison of ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
ESSENTIAL PROPERTIES REALTY TRUST, INC. is the larger business by last-quarter revenue ($158.8M vs $123.8M, roughly 1.3× NATURES SUNSHINE PRODUCTS INC). ESSENTIAL PROPERTIES REALTY TRUST, INC. runs the higher net margin — 37.8% vs 3.3%, a 34.4% gap on every dollar of revenue. On growth, ESSENTIAL PROPERTIES REALTY TRUST, INC. posted the faster year-over-year revenue change (22.8% vs 4.7%). Over the past eight quarters, ESSENTIAL PROPERTIES REALTY TRUST, INC.'s revenue compounded faster (20.6% CAGR vs 5.6%).
Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
EPRT vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.8M | $123.8M |
| Net Profit | $60.0M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 56.5% | 4.3% |
| Net Margin | 37.8% | 3.3% |
| Revenue YoY | 22.8% | 4.7% |
| Net Profit YoY | 6.5% | 1379.4% |
| EPS (diluted) | $0.28 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $158.8M | — | ||
| Q4 25 | $149.9M | $123.8M | ||
| Q3 25 | $144.9M | $128.3M | ||
| Q2 25 | $137.1M | $114.8M | ||
| Q1 25 | $129.4M | $113.2M | ||
| Q4 24 | $119.7M | $118.2M | ||
| Q3 24 | $117.1M | $114.6M | ||
| Q2 24 | $109.3M | $110.6M |
| Q1 26 | $60.0M | — | ||
| Q4 25 | $68.1M | $4.1M | ||
| Q3 25 | $65.6M | $5.3M | ||
| Q2 25 | $63.2M | $5.3M | ||
| Q1 25 | $56.1M | $4.7M | ||
| Q4 24 | $55.4M | $-321.0K | ||
| Q3 24 | $49.1M | $4.3M | ||
| Q2 24 | $51.5M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | 56.5% | — | ||
| Q4 25 | 65.9% | 4.3% | ||
| Q3 25 | 64.7% | 7.0% | ||
| Q2 25 | 64.1% | 3.7% | ||
| Q1 25 | 61.6% | 5.4% | ||
| Q4 24 | 66.1% | 3.8% | ||
| Q3 24 | 59.7% | 4.6% | ||
| Q2 24 | 61.1% | 5.1% |
| Q1 26 | 37.8% | — | ||
| Q4 25 | 45.4% | 3.3% | ||
| Q3 25 | 45.3% | 4.2% | ||
| Q2 25 | 46.1% | 4.6% | ||
| Q1 25 | 43.4% | 4.2% | ||
| Q4 24 | 46.3% | -0.3% | ||
| Q3 24 | 42.0% | 3.8% | ||
| Q2 24 | 47.1% | 1.2% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.34 | $0.23 | ||
| Q3 25 | $0.33 | $0.30 | ||
| Q2 25 | $0.32 | $0.28 | ||
| Q1 25 | $0.29 | $0.25 | ||
| Q4 24 | $0.31 | $-0.02 | ||
| Q3 24 | $0.27 | $0.23 | ||
| Q2 24 | $0.29 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.2M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4B | $161.6M |
| Total Assets | $7.2B | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $15.2M | — | ||
| Q4 25 | $60.2M | $93.9M | ||
| Q3 25 | $23.8M | $95.6M | ||
| Q2 25 | $20.8M | $81.3M | ||
| Q1 25 | $47.0M | $86.5M | ||
| Q4 24 | $40.7M | $84.7M | ||
| Q3 24 | $32.7M | $78.7M | ||
| Q2 24 | $23.6M | $68.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.2B | $161.6M | ||
| Q3 25 | $3.8B | $166.7M | ||
| Q2 25 | $3.8B | $163.7M | ||
| Q1 25 | $3.8B | $167.1M | ||
| Q4 24 | $3.6B | $161.0M | ||
| Q3 24 | $3.2B | $162.6M | ||
| Q2 24 | $3.2B | $156.4M |
| Q1 26 | $7.2B | — | ||
| Q4 25 | $6.9B | $261.1M | ||
| Q3 25 | $6.6B | $264.8M | ||
| Q2 25 | $6.3B | $254.9M | ||
| Q1 25 | $6.1B | $252.7M | ||
| Q4 24 | $5.8B | $240.9M | ||
| Q3 24 | $5.5B | $245.3M | ||
| Q2 24 | $5.3B | $235.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.59× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $381.1M | $9.9M | ||
| Q3 25 | $99.0M | $18.5M | ||
| Q2 25 | $99.8M | $4.3M | ||
| Q1 25 | $77.2M | $2.6M | ||
| Q4 24 | $308.5M | $12.2M | ||
| Q3 24 | $73.5M | $9.6M | ||
| Q2 24 | $81.1M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.60× | 2.41× | ||
| Q3 25 | 1.51× | 3.46× | ||
| Q2 25 | 1.58× | 0.81× | ||
| Q1 25 | 1.38× | 0.55× | ||
| Q4 24 | 5.57× | — | ||
| Q3 24 | 1.50× | 2.21× | ||
| Q2 24 | 1.57× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
